Telefonica Brasil SA (VIV)

12.01
NYSE : Communications
Prev Close 11.95
Day Low/High 11.89 / 12.11
52 Wk Low/High 11.20 / 17.33
Avg Volume 1.64M
Exchange NYSE
Shares Outstanding 1.12B
Market Cap 19.41B
EPS 0.80
P/E Ratio 15.52
Div & Yield 0.72 (8.44%)

Latest News

Avivagen Announces Positive Results From Swine Trial

Avivagen Announces Positive Results From Swine Trial

Results Demonstrate Increased Health in Sows and Increased Weaning Weight of Nursing Piglets

Avivagen Announces Positive Results From Dairy Cattle Trial

Avivagen Announces Positive Results From Dairy Cattle Trial

- Results confirm expanded market opportunity -

Vivendi and Sony Will be Winners As Music Streaming Takes Off Says Goldman Sachs

Vivendi and Sony Will be Winners As Music Streaming Takes Off Says Goldman Sachs

Streaming sales will increase nine-fold by 2030 to $28 billion with most of the benefits flowing back to the major music labels.

Spotify Moves One Step Closer to IPO With Possible Warner Royalty Deal

Spotify Moves One Step Closer to IPO With Possible Warner Royalty Deal

The licensing pact could happen by September.

Avivagen Provides Business Updates

Avivagen Announces Third Purchase Order Of OxC-Beta™ Livestock From UNAHCO Inc.

Significant increase in the magnitude of the purchase order

Trader's Daily Notebook: Is a Battered Brazil Worth a Buy?

Trader's Daily Notebook: Is a Battered Brazil Worth a Buy?

If you're going to buy on the dip, this is one heck of a dip.

Sense of the Markets: Bollore Only Evident Winner in Vivendi's Havas Bid

Sense of the Markets: Bollore Only Evident Winner in Vivendi's Havas Bid

The French billionaire and Vivendi chairman has failed to explain why a pay-TV and music business like Vivendi needs an advertising firm like Havas.

Ferrari, Manchester United going ex-dividend

Big names paying shareholders, but their yields are modest compared with others.

Avivagen Reports Positive Proof Of Concept In Preventing C. Difficile Infection

-First Potential Human Application for Avivagen's Proprietary Technology -

TheStreet Quant Rating: B- (Buy)